Method for Medical Imaging

Abstract

Provided is a method for medical imaging in a patient in need thereof, comprising administering a pharmaceutical composition comprising LS301 to the patient via slow intravenous injection at a dose between about 0.001 mg/kg and about 0.5 mg/kg. Also provided is a method for surgical removal of cancer in a patient in need thereof, comprising administering a pharmaceutical composition comprising LS301 to the patient via slow intravenous injection at a dose between about 0.025 mg/kg and about 0.001 mg/kg before surgery for cancer resection; imaging via near-infrared fluorescence of the LS301 to identify malignant tissue in the patient, wherein each patient serves as their own control in terms of the near-infrared (NIR) light on versus the NIR light off; and surgically removing the image-identified malignant tissue from the patient, wherein the imaging step occurs during the surgical removal step.

Dependencies are inferred from the claim text.